Literature DB >> 18351637

Development of a liquid enzyme-based ceruminolytic product.

Nuria Jimenez1, Marisa L Garcia, Javier Galan, Alberto Vallet, Geoffrey R Owen, G Michael Wall.   

Abstract

Various compositions for removal of human cerumen are marketed but they are not very effective. Therefore, a proteolytic enzyme-based ceruminolytic product was developed containing the enzyme, methyl trypsin, and sodium bicarbonate. Efficacy was optimized based on in vitro testing using both human and artificial cerumen preparations. Both qualitative (visual observation) and quantitative (spectrophotometric) assessments of ceruminolytic efficacy were employed. Optimal enzyme stability was observed for the aqueous formulation at pH 4, while greater ceruminolytic efficacy was observed at pH 8. The optimal concentration range of enzyme was 150-300 absorbance U/mL based on efficacy and stability considerations. An aqueous formulation containing both methyl trypsin and sodium bicarbonate was shown to be more effective than two commercial products, Murine Ear Wax Removal Drops and Cerumenex Ear Drops. A two-part packaging system was employed to provide adequate shelf-life. Long-term stability studies confirmed that the formulation maintained >75% enzyme stability for 24 months at 5 and 25 degrees C and after reconstitution at room temperature for up to 1 day.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351637     DOI: 10.1002/jps.21337

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Stability improvement of a liquid enzyme product.

Authors:  Núria Jiménez; Maria Luisa Garcia; Javier Galán; Alberto Vallet; Geoffrey Owen; G Michael Wall
Journal:  AAPS PharmSciTech       Date:  2009-11-04       Impact factor: 3.246

2.  Evaluation of the safety and efficacy of a novel product for the removal of impacted human cerumen.

Authors:  Douglas Fullington; Jenny Song; Antionette Gilles; Xiaowen Guo; Waley Hua; C Eric Anderson; Joseph Griffin
Journal:  BMC Ear Nose Throat Disord       Date:  2017-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.